Pfizer Sues Philippines Over Generic Norvasc

Law360, New York (March 8, 2006, 12:00 AM EST) -- U.S. Pharmaceutical giant Pfizer Inc. is taking on the Philippines to protect patents that cover its second best-selling drug Norvasc, only one month after a sweeping victory in U.S. courts cleared generic opposition.

Starting a new round of international litigation, Pfizer sued the Filipino government to prevent the nation from importing from India and Pakistan generic versions of the popular hypertension drug.

Pfizer filed the civil lawsuit in the Philippines after it learned that a government-owned importer and a local regulatory body allegedly planned to import...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.